Bone Grafts Research - Spine Fusion, Surgery, Procedure, Risks

Bone Grafts Research Today is a free monthly online journal that collates and summarizes the latest research about Bone Grafts, including details on spine fusion, surgery, procedure, risks.


Bone Grafts Research Today

Home

View Latest Issue

Information About Bone Grafts

Books on Bone Grafts

Advertising in Research Today

View Other Research Today Publications



Volume 6 (2009), Issue 2 (February)

  1. The effect of fibroblast growth factor-2 on autologous osteochondral transplantation.
    Int Orthop, 33(1): 275-80. [Abstract] [Full-text]
  2. Fixation with autogenous osteochondral grafts for the treatment of osteochondritis dissecans (stages III and IV).
    Int Orthop, 33(1): 139-44. [Abstract] [Full-text]
  3. Biomechanical evaluation of anterior cruciate ligament femoral fixation techniques.
    Am J Sports Med, 37(2): 339-45. [Abstract] [Full-text]
  4. The Schneiderian membrane contains osteoprogenitor cells: in vivo and in vitro study.
    Calcif Tissue Int, 84(2): 138-45. [Abstract] [Full-text]
  5. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.
    Haematologica, 94(2): 173-84. [Abstract] [Full-text]
  6. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice.
    J Thorac Cardiovasc Surg, 137(2): 471-80. [Abstract] [Full-text]
  7. Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice.
    Bone Marrow Transplant. [Abstract] [Full-text]
  8. Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience.
    Bone Marrow Transplant. [Abstract] [Full-text]
  9. Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant.
    Bone Marrow Transplant. [Abstract] [Full-text]
  10. Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience.
    Bone Marrow Transplant. [Abstract] [Full-text]
  11. Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants?
    Bone Marrow Transplant. [Abstract] [Full-text]
  12. Anterior cruciate ligament reconstruction with use of a single or double-bundle technique in patients with generalized ligamentous laxity.
    J Bone Joint Surg Am, 91(2): 257-62. [Abstract] [Full-text]
  13. Facial subunit composite tissue allografts in nonhuman primates: I. Technical and immunosuppressive requirements for prolonged graft survival.
    Plast Reconstr Surg, 123(2): 493-501. [Abstract] [Full-text]
  14. Bone-periosteum-bone graft reconstruction for chronic ulnar instability of the metacarpophalangeal joint of the thumb--minimum 5-year follow-up evaluation.
    J Hand Surg [Am], 34(2): 304-8. [Abstract] [Full-text]
  15. Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis.
    Gastroenterology, 136(2): 575-84.e2. [Abstract] [Full-text]
  16. Structural change of soft tissue anterior cruciate ligament reconstructions with cross-pin fixation between immediate and postoperative 8 weeks: a study with use of magnetic resonance imaging.
    Am J Sports Med, 37(2): 285-90. [Abstract] [Full-text]
  17. Maintenance of donor-specific chimerism despite osteopontin-associated bone fibrosis in a vascularized bone marrow transplantation model.
    Plast Reconstr Surg, 123(2): 34S-44S. [Abstract] [Full-text]
  18. Evaluation of knee stability with use of a robotic system.
    J Bone Joint Surg Am, 91: 78-84. [Abstract] [Full-text]
  19. Critical care outcomes in the hematologic transplant recipient.
    Clin Chest Med, 30(1): 155-67, ix-x. [Abstract] [Full-text]
  20. Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells.
    Cell Mol Life Sci, 66(3): 495-503. [Abstract] [Full-text]
  21. Craniomaxillofacial fibrous dysplasia: conservative treatment or radical surgery? A retrospective study on 68 patients.
    Plast Reconstr Surg, 123(2): 653-60. [Abstract] [Full-text]
  22. Documentation of the incidents associated with mandibular distraction: introduction of a new stratification system.
    Plast Reconstr Surg, 123(2): 627-34. [Abstract] [Full-text]
  23. Bone healing induced by local delivery of an engineered parathyroid hormone prodrug.
    Biomaterials, 30(9): 1763-71. [Abstract] [Full-text]
  24. Inhibition of Transforming Growth Factor beta Signaling by Halofuginone as a Modality for Pancreas Fibrosis Prevention.
    Pancreas. [Abstract] [Full-text]
  25. The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness.
    Clin Cancer Res, 15(3): 995-1004. [Abstract] [Full-text]
  26. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats.
    Neuropathol Appl Neurobiol, 35(1): 89-102. [Abstract] [Full-text]
  27. Magnesium-enriched hydroxyapatite compared to calcium sulfate in the healing of human extraction sockets: radiographic and histomorphometric evaluation at 3 months.
    J Periodontol, 80(2): 210-8. [Abstract] [Full-text]
  28. Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium.
    J Clin Invest, 119(2): 336-48. [Abstract] [Full-text]
  29. Long-term clinical outcomes following the use of synthetic hydroxyapatite and bone graft in impaction in revision hip arthroplasty.
    Biomaterials, 30(9): 1732-8. [Abstract] [Full-text]
  30. Purely cancellous vs. corticocancellous bone in sinus floor augmentation with autogenous iliac crest: a prospective clinical trial.
    Clin Oral Implants Res, 20(2): 109-15. [Abstract] [Full-text]
  31. Is an impacted morselized graft in a cage an alternative for reconstructing segmental diaphyseal defects?
    Clin Orthop Relat Res, 467(3): 783-91. [Abstract] [Full-text]
  32. Histological evaluation of the influence of magnetic field application in autogenous bone grafts in rats.
    Head Face Med, 5: 1. [Abstract] [Full-text]
  33. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients.
    Cytotherapy. [Abstract] [Full-text]
  34. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability.
    Cytotherapy. [Abstract] [Full-text]
  35. Cell therapy for disorders of bone.
    Cytotherapy. [Abstract] [Full-text]
  36. A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus.
    Cytotherapy. [Abstract] [Full-text]
  37. Reconstruction of Pediatric Cranial Base Defects: A Review of a Single Microsurgeon's 30-Year Experience.
    J Craniofac Surg. [Abstract] [Full-text]
  38. Fibular centralisation for the reconstruction of defects of the tibial diaphysis and distal metaphysis after excision of bone tumours.
    J Bone Joint Surg Br, 91(2): 234-9. [Abstract] [Full-text]
  39. Limitations of structural allograft in revision total knee arthroplasty.
    Clin Orthop Relat Res, 467(3): 818-24. [Abstract] [Full-text]
  40. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
    Blood, 113(6): 1304-14. [Abstract] [Full-text]
  41. Platelet Lysate as a Serum Substitute for 2D Static and 3D Perfusion Culture of Stromal Vascular Fraction Cells from Human Adipose Tissue.
    Tissue Eng Part A. [Abstract] [Full-text]
  42. In situ genetic analysis of cellular chimerism.
    Nat Med, 15(2): 215-9. [Abstract] [Full-text]
  43. MSC response to pH levels found in degenerating intervertebral discs.
    Biochem Biophys Res Commun, 379(4): 824-9. [Abstract] [Full-text]
  44. Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance.
    Cell Stem Cell, 4(2): 170-9. [Abstract] [Full-text]
  45. Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.
    J Clin Oncol, 27(5): 770-81. [Abstract] [Full-text]
  46. P-selectin-coated microtube for the purification of CD45+ hematopoietic cells directly from human peripheral blood.
    Blood Cells Mol Dis, 42(2): 136-9. [Abstract] [Full-text]
  47. Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials.
    Transplantation, 87(3): 309-16. [Abstract] [Full-text]
  48. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
    J Immunol, 182(4): 1818-28. [Abstract] [Full-text]
  49. Multiplanar and combined distraction osteogenesis for three-dimensional and functional reconstruction of unilateral large maxillary defects.
    Br J Oral Maxillofac Surg, 47(2): 106-10. [Abstract] [Full-text]
  50. NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.
    Am J Respir Cell Mol Biol, 40(3): 375-81. [Abstract] [Full-text]
  51. Acute graft extrusion following central corpectomy in patients with cervical spondylotic myelopathy and ossified posterior longitudinal ligament.
    J Clin Neurosci, 16(3): 373-7. [Abstract] [Full-text]
  52. Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.
    Circulation, 119(5): 699-708. [Abstract] [Full-text]
  53. BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma.
    Bone Marrow Transplant. [Abstract] [Full-text]
  54. Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post Auto-SCT and its correlation with survival outcome.
    Bone Marrow Transplant. [Abstract] [Full-text]
  55. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (Allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
    Bone Marrow Transplant. [Abstract] [Full-text]
  56. Advances in basic and clinical immunology in 2008.
    J Allergy Clin Immunol, 123(2): 328-32. [Abstract] [Full-text]
  57. CARDIAC REPAIR WITH ADULT BONE MARROW-DERIVED CELLS: THE CLINICAL EVIDENCE.
    Antioxid Redox Signal. [Abstract] [Full-text]
  58. Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.
    Biol Blood Marrow Transplant, 15(3): 360-6. [Abstract] [Full-text]
  59. Prognostic utility of routine chimerism testing at 2 to 6 months after allogeneic hematopoietic cell transplantation.
    Biol Blood Marrow Transplant, 15(3): 352-9. [Abstract] [Full-text]
  60. Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
    Biol Blood Marrow Transplant, 15(3): 326-35. [Abstract] [Full-text]
  61. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Biol Blood Marrow Transplant, 15(3): 306-14. [Abstract] [Full-text]
  62. Hematopoietic stem cell transplantation for bone marrow failure syndromes in children.
    Biol Blood Marrow Transplant, 15(3): 279-92. [Abstract] [Full-text]
  63. Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice.
    Am J Respir Cell Mol Biol, 40(3): 295-304. [Abstract] [Full-text]
  64. Bone mass and microarchitecture of irradiated and bone marrow-transplanted mice: influences of the donor strain.
    Osteoporos Int, 20(3): 435-43. [Abstract] [Full-text]
  65. Allogeneic bone marrow transplantation and donor lymphocyte infusion in a mouse model of irradiation-induced myelodysplastic/myeloproliferation syndrome (MD/MPS): evidence for a graft-versus-MD/MPS effect.
    Leukemia, 23(2): 340-9. [Abstract] [Full-text]
  66. E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors.
    Proc Natl Acad Sci U S A, 106(6): 1930-5. [Abstract] [Full-text]
  67. Hip transposition as a universal surgical procedure for periacetabular tumors of the pelvis.
    J Surg Oncol, 99(3): 169-72. [Abstract] [Full-text]
  68. Multifocal osteomyelitis caused by Candida dubliniensis.
    J Med Microbiol, 58: 386-90. [Abstract] [Full-text]
  69. Studies on dentin grafts to bone defects in rabbit tibia and mandible; development of an experimental model.
    Dent Traumatol, 25(1): 78-83. [Abstract] [Full-text]
  70. Bone replacement following dental trauma prior to implant surgery--status.
    Dent Traumatol, 25(1): 2-11. [Abstract] [Full-text]
  71. Implants placed in combination with an internal sinus lift without graft material: an analysis of short-term failure.
    J Clin Periodontol, 36(2): 177-83. [Abstract] [Full-text]
  72. Mandibles grafted with fresh-frozen bone: an evaluation of implant outcome.
    Implant Dent, 18(1): 86-95. [Abstract] [Full-text]
  73. Functional outcomes of arthroscopic posterior cruciate ligament reconstruction: comparison of anteromedial and anterolateral trans-tibia approach.
    Arch Orthop Trauma Surg, 129(3): 315-21. [Abstract] [Full-text]
  74. G2A deficiency in mice promotes macrophage activation and atherosclerosis.
    Circ Res, 104(3): 318-27. [Abstract] [Full-text]
  75. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods.
    Spine, 34(4): 328-34. [Abstract] [Full-text]
  76. Prophylactic cranial irradiation in advanced breast cancer: a case for caution.
    Int J Radiat Oncol Biol Phys, 73(3): 752-8. [Abstract] [Full-text]
  77. Augmentation of skeletal tissue formation in impaction bone grafting using vaterite microsphere biocomposites.
    Biomaterials, 30(10): 1918-27. [Abstract] [Full-text]
  78. Fungal infection as a complication of sinus bone grafting and implants: a case report.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107(3): 375-80. [Abstract] [Full-text]
  79. Effect of risedronate in a minipig cartilage defect model with allograft.
    J Orthop Res, 27(3): 360-5. [Abstract] [Full-text]
  80. Measurement of volume changes of sinus floor augmentation covered with buccal fat pad: a case series study.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107(3): 369-74. [Abstract] [Full-text]
  81. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats.
    Transpl Immunol, 20(4): 232-7. [Abstract] [Full-text]
  82. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
    Exp Neurol, 216(1): 47-55. [Abstract] [Full-text]
  83. Fixation of autogenous bone grafts with ethyl-cyanoacrylate glue or titanium screws in the calvaria of rabbits.
    Int J Oral Maxillofac Surg, 38(2): 180-6. [Abstract] [Full-text]
  84. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100.
    Exp Hematol, 37(3): 402-15.e1. [Abstract] [Full-text]
  85. Heterogeneous expression of HLA-G1, -G2, -G5, -G6, and -G7 in myeloid and plasmacytoid dendritic cells isolated from umbilical cord blood.
    Hum Immunol, 70(2): 104-9. [Abstract] [Full-text]
  86. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
    Bone Marrow Transplant. [Abstract] [Full-text]
  87. Advances in hematologic stem cell transplant: an update for oral health care providers.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107(3): 301-12. [Abstract] [Full-text]
  88. Stereoselective Synthesis and Osteogenic Activity of Subglutinols A and B.
    J Am Chem Soc. [Abstract] [Full-text]
  89. Orthodontic treatment including autotransplantation of a mature tooth.
    Angle Orthod, 79(2): 387-93. [Abstract] [Full-text]
  90. Catastrophic gastrointestinal manifestations of post-transplant lymphoproliferative disorder.
    Dig Liver Dis, 41(3): 238-41. [Abstract] [Full-text]
  91. The fate of transplanted xenogeneic bone marrow-derived stem cells in rat intervertebral discs.
    J Orthop Res, 27(3): 374-9. [Abstract] [Full-text]
  92. Enhancement of posterolateral lumbar spine fusion using low-dose rhBMP-2 and cultured marrow stromal cells.
    J Orthop Res, 27(3): 380-4. [Abstract] [Full-text]
  93. Healing ligament mechanical properties are improved by repair with interpositional allografts but not by concomitant treatment with hyaluronic acid.
    J Orthop Res, 27(3): 400-7. [Abstract] [Full-text]
  94. Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model.
    J Orthop Res, 27(3): 366-73. [Abstract] [Full-text]
  95. Stem cell-mediated accelerated bone healing observed with in vivo molecular and small animal imaging technologies in a model of skeletal injury.
    J Orthop Res, 27(3): 295-302. [Abstract] [Full-text]
  96. The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.
    Dev Biol, 327(1): 24-33. [Abstract] [Full-text]
  97. MLL5 contributes to hematopoietic stem cell fitness and homeostasis.
    Blood, 113(7): 1455-63. [Abstract] [Full-text]
  98. CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure.
    Blood, 113(7): 1504-12. [Abstract] [Full-text]
  99. Impaired function of primitive hematopoietic cells in mice lacking the Mixed-Lineage-Leukemia homolog MLL5.
    Blood, 113(7): 1444-54. [Abstract] [Full-text]
  100. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
    Blood, 113(7): 1574-80. [Abstract] [Full-text]
  101. Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?
    Eur J Nucl Med Mol Imaging, 36(3): 484-98. [Abstract] [Full-text]
  102. Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation.
    J Exp Med, 206(2): 371-85. [Abstract] [Full-text]
  103. Mesenchymal stem cells: flip side of the coin.
    Cancer Res, 69(4): 1255-8. [Abstract] [Full-text]
  104. A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.
    Cancer Res, 69(4): 1685-92. [Abstract] [Full-text]
  105. Posterior Reversible Encephalopathy Syndrome Associated with Hemorrhage.
    Neurocrit Care. [Abstract] [Full-text]
  106. Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells.
    PLoS ONE, 4(2): e4529. [Abstract] [Full-text]
  107. Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.
    Blood, 113(8): 1681-8. [Abstract] [Full-text]
  108. Pedicled vascularized bone graft from the medial supracondylar region of the femur for treatment of femur nonunion.
    J Reconstr Microsurg, 25(3): 165-70. [Abstract] [Full-text]
  109. Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation.
    Blood, 113(8): 1834-40. [Abstract] [Full-text]
  110. Improved outcome of allogeneic bone marrow transplantation due to breastfeeding-induced tolerance to maternal antigens.
    Blood, 113(8): 1829-33. [Abstract] [Full-text]
  111. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
    Blood, 113(8): 1631-8. [Abstract] [Full-text]
  112. Oxalosis in primary hyperoxaluria in infancy : Report of a case in a 3-month-old baby. Follow-up for 3 years and review of literature.
    Skeletal Radiol, 38(4): 387-91. [Abstract] [Full-text]
  113. Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
    Clin Cancer Res, 15(4): 1343-52. [Abstract] [Full-text]
  114. Menin regulates the function of hematopoietic stem cells and lymphoid progenitors.
    Blood, 113(8): 1661-9. [Abstract] [Full-text]
  115. Preclinical studies in support of defibrotide for the treatment of multiple myeloma and other neoplasias.
    Clin Cancer Res, 15(4): 1210-21. [Abstract] [Full-text]
  116. Interventions for replacing missing teeth: bone augmentation techniques for dental implant treatment.
    Aust Dent J, 54(1): 70-1. [Abstract] [Full-text]
  117. Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.
    Leuk Res, 33(4): 525-38. [Abstract] [Full-text]
  118. The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo.
    Biomaterials, 30(11): 2032-7. [Abstract] [Full-text]
  119. Curettage of benign bone tumors without grafts gives sufficient bone strength.
    Acta Orthop, 80(1): 9-13. [Abstract] [Full-text]
  120. A randomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
  121. Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.
    Bone Marrow Transplant. [Abstract] [Full-text]
  122. Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. [Abstract] [Full-text]
  123. Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Bone Marrow Transplant. [Abstract] [Full-text]
  124. Cancer stem cells: relevance to SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
  125. Longitudinal health-related quality of life outcomes and related factors after pediatric SCT.
    Bone Marrow Transplant. [Abstract] [Full-text]
  126. Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse.
    Am J Pathol, 174(3): 727-35. [Abstract] [Full-text]
  127. Chemokine receptor CXCR5 supports solitary intestinal lymphoid tissue formation, B cell homing, and induction of intestinal IgA responses.
    J Immunol, 182(5): 2610-9. [Abstract] [Full-text]
  128. Resection of a large, central hemangioma with reconstruction using a radial forearm flap combined with zygomatic and pterygoid implants.
    J Oral Maxillofac Surg, 67(3): 630-6. [Abstract] [Full-text]
  129. Clinical evaluation of a modified method of vestibuloplasty using an implant-retained splint.
    J Oral Maxillofac Surg, 67(3): 624-9. [Abstract] [Full-text]
  130. Le Fort I osteotomy, bilateral sinus lift, and inlay bone-grafting for reconstruction in the severely atrophic maxilla: a new vision of the sandwich technique, using bone scrapers and piezosurgery.
    J Oral Maxillofac Surg, 67(3): 613-8. [Abstract] [Full-text]
  131. Morbidity from anterior iliac crest bone harvesting for secondary alveolar bone grafting: an outcome assessment study.
    J Oral Maxillofac Surg, 67(3): 570-5. [Abstract] [Full-text]
  132. Minimally invasive mitral valve surgery after previous sternotomy: experience in 181 patients.
    Ann Thorac Surg, 87(3): 709-14. [Abstract] [Full-text]
  133. Body wall morphogenesis: limb-genesis interferes with body wall-genesis via its influence on the abaxial somite derivatives.
    Mech Dev, 126(3): 198-211. [Abstract] [Full-text]
  134. Reconstruction of a composite anterior mandibular defect with horizontal sliding osteotomies and an osteocutaneous forearm free flap: a case report.
    J Plast Reconstr Aesthet Surg, 62(3): e65-8. [Abstract] [Full-text]
  135. Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells.
    Crit Care Med, 37(3): 833-9. [Abstract] [Full-text]
  136. Immunologic reconstitution in 22q deletion (DiGeorge) syndrome.
    Immunol Res. [Abstract] [Full-text]
  137. Treatment of incomplete ossification of the humeral condyle with autogenous bone grafting techniques.
    Vet Surg, 38(2): 173-84. [Abstract] [Full-text]
  138. L-form plastics in the treatment of post-burn trophic ulcers and cicatrices of the foot calcaneal area.
    J Plast Reconstr Aesthet Surg, 62(3): e59-63. [Abstract] [Full-text]
  139. Alefacept treatment for refractory chronic extensive GVHD.
    Bone Marrow Transplant, 43(4): 339-43. [Abstract] [Full-text]
  140. Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
    Bone Marrow Transplant, 43(4): 293-300. [Abstract] [Full-text]
  141. Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.
    Bone Marrow Transplant, 43(4): 307-14. [Abstract] [Full-text]
  142. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells.
    Immunity, 30(2): 218-27. [Abstract] [Full-text]
  143. Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix.
    Ann Plast Surg, 62(3): 317-21. [Abstract] [Full-text]
  144. Soft tissue reconstruction using vascularized tissue transplantation following resection of musculoskeletal sarcoma: evaluation of oncologic and functional outcomes in 55 cases.
    Ann Plast Surg, 62(3): 252-7. [Abstract] [Full-text]
  145. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
    Transfusion, 49(3): 555-62. [Abstract] [Full-text]
  146. 3D culture of osteoblast-like cells by unidirectional or oscillatory flow for bone tissue engineering.
    Biotechnol Bioeng, 102(6): 1670-8. [Abstract] [Full-text]
  147. Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the NOD/SCID mouse.
    Exp Biol Med (Maywood), 234(3): 342-53. [Abstract] [Full-text]
  148. A Role of Myocardial Stiffness In Cell-based Cardiac Repair: A Hypothesis.
    J Cell Mol Med. [Abstract] [Full-text]
  149. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
    Curr Opin Pediatr, 21(1): 30-8. [Abstract] [Full-text]
  150. Myeloid cells control termination of lung inflammation through the NF-kappaB pathway.
    Am J Physiol Lung Cell Mol Physiol, 296(3): L320-7. [Abstract] [Full-text]
  151. Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo.
    Blood, 113(9): 2104-7. [Abstract] [Full-text]
  152. Vitamin D supplementation after renal transplantation: how much vitamin D should we prescribe?
    Kidney Int, 75(6): 576-8. [Abstract] [Full-text]
  153. Cell fusion contributes to pericyte formation after stroke.
    J Cereb Blood Flow Metab, 29(3): 480-5. [Abstract] [Full-text]
  154. Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.
    Blood, 113(9): 1992-2002. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2010 Bone Grafts Research Today. All Rights Reserved.



Bone Grafts Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)



Bone Grafts Books

Graft-Versus-host Disease (Medical Intelligence Unit)

Graft-Versus-host Disease (Medical Intelligence Unit)